1820P Cardiovascular effects of androgen receptor signalling inhibitors in the treatment of advanced and metastatic prostate cancer: A systematic review and meta-analysis of randomised controlled trials

O El-Taji; Craig Jones; MD Brown; NW Clarke; A Sachdeva

doi:10.1016/j.annonc.2023.09.2768

1820P Cardiovascular effects of androgen receptor signalling inhibitors in the treatment of advanced and metastatic prostate cancer: A systematic review and meta-analysis of randomised controlled trials

O El-Taji, Craig Jones, MD Brown, NW Clarke, A Sachdeva

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S986-S986
Number of pages	1
Journal	Annals of Oncology
Volume	34
DOIs	https://doi.org/10.1016/j.annonc.2023.09.2768
Publication status	Published - 20 Oct 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.annonc.2023.09.2768

Cite this

@article{b3656fdb865d411dab6ef96fb2fb2508,

title = "1820P Cardiovascular effects of androgen receptor signalling inhibitors in the treatment of advanced and metastatic prostate cancer: A systematic review and meta-analysis of randomised controlled trials",

author = "O El-Taji and Craig Jones and MD Brown and NW Clarke and A Sachdeva",

year = "2023",

month = oct,

day = "20",

doi = "10.1016/j.annonc.2023.09.2768",

language = "English",

volume = "34",

pages = "S986--S986",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

1820P Cardiovascular effects of androgen receptor signalling inhibitors in the treatment of advanced and metastatic prostate cancer: A systematic review and meta-analysis of randomised controlled trials. / El-Taji, O; Jones, Craig; Brown, MD et al.
In: Annals of Oncology, Vol. 34, 20.10.2023, p. S986-S986.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - 1820P Cardiovascular effects of androgen receptor signalling inhibitors in the treatment of advanced and metastatic prostate cancer

T2 - A systematic review and meta-analysis of randomised controlled trials

AU - El-Taji, O

AU - Jones, Craig

AU - Brown, MD

AU - Clarke, NW

AU - Sachdeva, A

PY - 2023/10/20

Y1 - 2023/10/20

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_starter&SrcAuth=WosAPI&KeyUT=WOS:001087480202488&DestLinkType=FullRecord&DestApp=WOS

UR - https://www.mendeley.com/catalogue/88e876c6-ef17-3368-b0bd-290aa8133c82/

U2 - 10.1016/j.annonc.2023.09.2768

DO - 10.1016/j.annonc.2023.09.2768

M3 - Meeting Abstract

SN - 0923-7534

VL - 34

SP - S986-S986

JO - Annals of Oncology

JF - Annals of Oncology

ER -

1820P Cardiovascular effects of androgen receptor signalling inhibitors in the treatment of advanced and metastatic prostate cancer: A systematic review and meta-analysis of randomised controlled trials

UN SDGs

Access to Document

Other files and links

Cite this